Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application

In our study, Voriconazole (VOR) was selected as an active agent to be used for the treatment of ocular fungal infections. To overcome low aqueous solubility of VOR, inclusion complexes with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), γ-cyclodextrin (γ-CD), hydroxypropyl-cyclodextrin (HP-CD), hydr...

Full description

Saved in:
Bibliographic Details
Published in:Pharmaceutical development and technology 2022-02, Vol.27 (2), p.228-241
Main Authors: Başaran, Ebru, Aykaç, Kadir, Yenilmez, Evrim, Büyükköroğlu, Gülay, Tunali, Yağmur, Demirel, Müzeyyen
Format: Article
Language:English
Subjects:
2-Hydroxypropyl-beta-cyclodextrin
Animals
antifungal activity
beta-Cyclodextrins
inclusion complexes
lyophilization
Mice
Mycoses
Solubility
Voriconazole
Voriconazole - pharmacology
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3
cites cdi_FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3
container_end_page 241
container_issue 2
container_start_page 228
container_title Pharmaceutical development and technology
container_volume 27
creator Başaran, Ebru
Aykaç, Kadir
Yenilmez, Evrim
Büyükköroğlu, Gülay
Tunali, Yağmur
Demirel, Müzeyyen
description In our study, Voriconazole (VOR) was selected as an active agent to be used for the treatment of ocular fungal infections. To overcome low aqueous solubility of VOR, inclusion complexes with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), γ-cyclodextrin (γ-CD), hydroxypropyl-cyclodextrin (HP-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) hydroxypropyl-γ-cyclodextrin (HP-γ-CD), methyl-β-cyclodextrin (M-β-CD) and sulfabutylether-β-cyclodextrin (SBE-β-CD) were formulated. Characterization studies revealed that inclusion complexes were formulated successfully with the lyophilization method. Aqueous solubility of VOR was enhanced up to 86 fold with the formation of the inclusion complexes. MTT analyses results revealed the safety of the complexes on 3T3 mouse fibroblast cell lines while Microbroth Dilution Method revealed the remarkable antifungal activities of the complexes. Analyses results revealed that inclusion complexes will overcome the poor ocular bioavailability of VOR resulting inefficient treatment of severe ocular fungal infections.
doi_str_mv 10.1080/10837450.2022.2037635
format article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_35107405</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2624953409</sourcerecordid><originalsourceid>FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3</originalsourceid><addsrcrecordid>eNp9kM1O3TAQha2qVS9ceIRWWXYTOo7jON5RIf4kpG7atTWxHWHkxKmdUODpcZoLy25mxkdnzlgfIV8onFFo4XsuTNQcziqoqlyYaBj_QI4oSFHKthEf17ll5WrakeOUHgBoK4F_JjvGKYga-BEJVyEOi8fZhbHA0RT6HiPq2Ub3solpXoyzqQh94Ubtl7SKOgyTt0-b_Bii02HEl-Bt0YdYTCEl1-VH0Dk6FjhN3ul_cSfkU48-2dND35PfV5e_Lm7Ku5_Xtxc_7krNmmYua2wN10ihga7TVFhDOa2wktb0FLQBDUKgpKzhlHVWcCtr25hK1thB13dsT75tuVMMfxabZjW4pK33ONqwJFU1VS05q0FmK9-sOuZ_R9urKboB47OioFbW6o21WlmrA-u89_VwYukGa9633uBmw_lmcGOmMuDfEL1RMz77EPuIo3ZJsf_feAVJIpDp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2624953409</pqid></control><display><type>article</type><title>Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application</title><source>Business Source Ultimate</source><source>Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)</source><creator>Başaran, Ebru ; Aykaç, Kadir ; Yenilmez, Evrim ; Büyükköroğlu, Gülay ; Tunali, Yağmur ; Demirel, Müzeyyen</creator><creatorcontrib>Başaran, Ebru ; Aykaç, Kadir ; Yenilmez, Evrim ; Büyükköroğlu, Gülay ; Tunali, Yağmur ; Demirel, Müzeyyen</creatorcontrib><description>In our study, Voriconazole (VOR) was selected as an active agent to be used for the treatment of ocular fungal infections. To overcome low aqueous solubility of VOR, inclusion complexes with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), γ-cyclodextrin (γ-CD), hydroxypropyl-cyclodextrin (HP-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) hydroxypropyl-γ-cyclodextrin (HP-γ-CD), methyl-β-cyclodextrin (M-β-CD) and sulfabutylether-β-cyclodextrin (SBE-β-CD) were formulated. Characterization studies revealed that inclusion complexes were formulated successfully with the lyophilization method. Aqueous solubility of VOR was enhanced up to 86 fold with the formation of the inclusion complexes. MTT analyses results revealed the safety of the complexes on 3T3 mouse fibroblast cell lines while Microbroth Dilution Method revealed the remarkable antifungal activities of the complexes. Analyses results revealed that inclusion complexes will overcome the poor ocular bioavailability of VOR resulting inefficient treatment of severe ocular fungal infections.</description><identifier>ISSN: 1083-7450</identifier><identifier>EISSN: 1097-9867</identifier><identifier>DOI: 10.1080/10837450.2022.2037635</identifier><identifier>PMID: 35107405</identifier><language>eng</language><publisher>England: Taylor &amp; Francis</publisher><subject>2-Hydroxypropyl-beta-cyclodextrin ; Animals ; antifungal activity ; beta-Cyclodextrins ; inclusion complexes ; lyophilization ; Mice ; Mycoses ; Solubility ; Voriconazole ; Voriconazole - pharmacology</subject><ispartof>Pharmaceutical development and technology, 2022-02, Vol.27 (2), p.228-241</ispartof><rights>2022 Informa UK Limited, trading as Taylor &amp; Francis Group 2022</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3</citedby><cites>FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3</cites><orcidid>0000-0003-2104-2069 ; 0000-0001-9927-683X ; 0000-0002-7979-0089</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35107405$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Başaran, Ebru</creatorcontrib><creatorcontrib>Aykaç, Kadir</creatorcontrib><creatorcontrib>Yenilmez, Evrim</creatorcontrib><creatorcontrib>Büyükköroğlu, Gülay</creatorcontrib><creatorcontrib>Tunali, Yağmur</creatorcontrib><creatorcontrib>Demirel, Müzeyyen</creatorcontrib><title>Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application</title><title>Pharmaceutical development and technology</title><addtitle>Pharm Dev Technol</addtitle><description>In our study, Voriconazole (VOR) was selected as an active agent to be used for the treatment of ocular fungal infections. To overcome low aqueous solubility of VOR, inclusion complexes with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), γ-cyclodextrin (γ-CD), hydroxypropyl-cyclodextrin (HP-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) hydroxypropyl-γ-cyclodextrin (HP-γ-CD), methyl-β-cyclodextrin (M-β-CD) and sulfabutylether-β-cyclodextrin (SBE-β-CD) were formulated. Characterization studies revealed that inclusion complexes were formulated successfully with the lyophilization method. Aqueous solubility of VOR was enhanced up to 86 fold with the formation of the inclusion complexes. MTT analyses results revealed the safety of the complexes on 3T3 mouse fibroblast cell lines while Microbroth Dilution Method revealed the remarkable antifungal activities of the complexes. Analyses results revealed that inclusion complexes will overcome the poor ocular bioavailability of VOR resulting inefficient treatment of severe ocular fungal infections.</description><subject>2-Hydroxypropyl-beta-cyclodextrin</subject><subject>Animals</subject><subject>antifungal activity</subject><subject>beta-Cyclodextrins</subject><subject>inclusion complexes</subject><subject>lyophilization</subject><subject>Mice</subject><subject>Mycoses</subject><subject>Solubility</subject><subject>Voriconazole</subject><subject>Voriconazole - pharmacology</subject><issn>1083-7450</issn><issn>1097-9867</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNp9kM1O3TAQha2qVS9ceIRWWXYTOo7jON5RIf4kpG7atTWxHWHkxKmdUODpcZoLy25mxkdnzlgfIV8onFFo4XsuTNQcziqoqlyYaBj_QI4oSFHKthEf17ll5WrakeOUHgBoK4F_JjvGKYga-BEJVyEOi8fZhbHA0RT6HiPq2Ub3solpXoyzqQh94Ubtl7SKOgyTt0-b_Bii02HEl-Bt0YdYTCEl1-VH0Dk6FjhN3ul_cSfkU48-2dND35PfV5e_Lm7Ku5_Xtxc_7krNmmYua2wN10ihga7TVFhDOa2wktb0FLQBDUKgpKzhlHVWcCtr25hK1thB13dsT75tuVMMfxabZjW4pK33ONqwJFU1VS05q0FmK9-sOuZ_R9urKboB47OioFbW6o21WlmrA-u89_VwYukGa9633uBmw_lmcGOmMuDfEL1RMz77EPuIo3ZJsf_feAVJIpDp</recordid><startdate>20220207</startdate><enddate>20220207</enddate><creator>Başaran, Ebru</creator><creator>Aykaç, Kadir</creator><creator>Yenilmez, Evrim</creator><creator>Büyükköroğlu, Gülay</creator><creator>Tunali, Yağmur</creator><creator>Demirel, Müzeyyen</creator><general>Taylor &amp; Francis</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-2104-2069</orcidid><orcidid>https://orcid.org/0000-0001-9927-683X</orcidid><orcidid>https://orcid.org/0000-0002-7979-0089</orcidid></search><sort><creationdate>20220207</creationdate><title>Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application</title><author>Başaran, Ebru ; Aykaç, Kadir ; Yenilmez, Evrim ; Büyükköroğlu, Gülay ; Tunali, Yağmur ; Demirel, Müzeyyen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>2-Hydroxypropyl-beta-cyclodextrin</topic><topic>Animals</topic><topic>antifungal activity</topic><topic>beta-Cyclodextrins</topic><topic>inclusion complexes</topic><topic>lyophilization</topic><topic>Mice</topic><topic>Mycoses</topic><topic>Solubility</topic><topic>Voriconazole</topic><topic>Voriconazole - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Başaran, Ebru</creatorcontrib><creatorcontrib>Aykaç, Kadir</creatorcontrib><creatorcontrib>Yenilmez, Evrim</creatorcontrib><creatorcontrib>Büyükköroğlu, Gülay</creatorcontrib><creatorcontrib>Tunali, Yağmur</creatorcontrib><creatorcontrib>Demirel, Müzeyyen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Pharmaceutical development and technology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Başaran, Ebru</au><au>Aykaç, Kadir</au><au>Yenilmez, Evrim</au><au>Büyükköroğlu, Gülay</au><au>Tunali, Yağmur</au><au>Demirel, Müzeyyen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application</atitle><jtitle>Pharmaceutical development and technology</jtitle><addtitle>Pharm Dev Technol</addtitle><date>2022-02-07</date><risdate>2022</risdate><volume>27</volume><issue>2</issue><spage>228</spage><epage>241</epage><pages>228-241</pages><issn>1083-7450</issn><eissn>1097-9867</eissn><abstract>In our study, Voriconazole (VOR) was selected as an active agent to be used for the treatment of ocular fungal infections. To overcome low aqueous solubility of VOR, inclusion complexes with α-cyclodextrin (α-CD), β-cyclodextrin (β-CD), γ-cyclodextrin (γ-CD), hydroxypropyl-cyclodextrin (HP-CD), hydroxypropyl-β-cyclodextrin (HP-β-CD) hydroxypropyl-γ-cyclodextrin (HP-γ-CD), methyl-β-cyclodextrin (M-β-CD) and sulfabutylether-β-cyclodextrin (SBE-β-CD) were formulated. Characterization studies revealed that inclusion complexes were formulated successfully with the lyophilization method. Aqueous solubility of VOR was enhanced up to 86 fold with the formation of the inclusion complexes. MTT analyses results revealed the safety of the complexes on 3T3 mouse fibroblast cell lines while Microbroth Dilution Method revealed the remarkable antifungal activities of the complexes. Analyses results revealed that inclusion complexes will overcome the poor ocular bioavailability of VOR resulting inefficient treatment of severe ocular fungal infections.</abstract><cop>England</cop><pub>Taylor &amp; Francis</pub><pmid>35107405</pmid><doi>10.1080/10837450.2022.2037635</doi><tpages>14</tpages><orcidid>https://orcid.org/0000-0003-2104-2069</orcidid><orcidid>https://orcid.org/0000-0001-9927-683X</orcidid><orcidid>https://orcid.org/0000-0002-7979-0089</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 1083-7450
ispartof Pharmaceutical development and technology, 2022-02, Vol.27 (2), p.228-241
issn 1083-7450
1097-9867
language eng
recordid cdi_pubmed_primary_35107405
source Business Source Ultimate; Taylor and Francis:Jisc Collections:Taylor and Francis Read and Publish Agreement 2024-2025:Medical Collection (Reading list)
subjects 2-Hydroxypropyl-beta-cyclodextrin
Animals
antifungal activity
beta-Cyclodextrins
inclusion complexes
lyophilization
Mice
Mycoses
Solubility
Voriconazole
Voriconazole - pharmacology
title Formulation and characterization studies of inclusion complexes of voriconazole for possible ocular application
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T04%3A25%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Formulation%20and%20characterization%20studies%20of%20inclusion%20complexes%20of%20voriconazole%20for%20possible%20ocular%20application&rft.jtitle=Pharmaceutical%20development%20and%20technology&rft.au=Ba%C5%9Faran,%20Ebru&rft.date=2022-02-07&rft.volume=27&rft.issue=2&rft.spage=228&rft.epage=241&rft.pages=228-241&rft.issn=1083-7450&rft.eissn=1097-9867&rft_id=info:doi/10.1080/10837450.2022.2037635&rft_dat=%3Cproquest_pubme%3E2624953409%3C/proquest_pubme%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c366t-4a8d5ca1060bbc17ed1512a29edf10cd0c077a9136513be75e94e6d294ab0bfb3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2624953409&rft_id=info:pmid/35107405&rfr_iscdi=true